<DOC>
	<DOCNO>NCT00465218</DOCNO>
	<brief_summary>The purpose study determine difference count cerebral embolus platelet function two prophylactic treatment thrombosis currently use University Ottawa Heart Institute first three month surgery low-risk patient undergoing aortic valve replacement bioprosthetic valve : 1 ) daily use high-dose aspirin [ 325 mg ] , 2 ) combination oral Warfarin [ target INR 2.0 3.0 ] low-dose aspirin [ 81 mg ] .</brief_summary>
	<brief_title>Transcranial Doppler ( TCD ) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement</brief_title>
	<detailed_description>Background : There several medication use prevent blood clot patient undergoing surgical replacement aortic valve tissue valve . One medication call warfarin ( Coumadin Â® ) prevent blood clot make blood `` thinner . '' Another medication aspirin prevents aggregation ( cluster ) cell blood call platelet . Some clinician consider use aspirin enough protect patient presence clot blood , others consider aspirin combine warfarin good protection . Moreover , physician express concern use oral anticoagulation due possibility increase risk bleeding . The effect medication prevent blood clot travel brain surgery currently unknown . Transcranial doppler ultrasound use patient evaluate non-invasively quantity fragment clot circulate artery brain . In addition , platelet function measure determine effective treatment prevent aggregation blood cell call platelet , may involve clot formation . Objective : Our purpose determine difference count cerebral embolus platelet function two prophylactic treatment thrombosis currently use institution first three month surgery patient : 1 ) daily use high-dose aspirin [ 325 mg ] , 2 ) combination oral Warfarin [ target INR 2.0 3.0 ] low-dose aspirin [ 81 mg ] . Methods : Patients low risk profile undergo primary aortic valve replacement bioprosthetic ( tissue ) valve eligible study . Patients receive one two prophylactic treatment thrombosis ( 1 2 ) depend surgeon 's preference . Platelet function measure surgery transcranial doppler within first 24 hour immediately surgery . At end one month follow surgery , patient undergo transcranial doppler platelet function assessment . The study power demonstrate hypothesis substantial equivalence two treatment regard primary outcome ( cerebral embolus ) . Outcome measure : 1 . Primary outcome : Bilateral count cerebral embolus middle cerebral artery transcranial doppler ultrasound one month surgery 2 . Secondary outcome : Platelet function , incidence major adverse neurologic bleed event one month follow surgery</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients undergo primary aortic valve replacement bioprosthetic ( tissue ) valve . Emergency surgery redo operation . Patients history transient ischemic attack , stroke , history carotid stenosis great 50 % detect carotid duplex doppler angiography . Patients COPD CO2 retainer . Patients LV function le 50 % , enlarge leave ventricle great 50 mm detect echocardiography previous history thromboembolism . Patients history atrial fibrillation heart rhythm disturbance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Bioprosthesis</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Cerebral embolus</keyword>
	<keyword>Transcranial Doppler</keyword>
	<keyword>Platelet function test</keyword>
</DOC>